Quest Diagnostics (DGX.N) on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped the company beat second-quarter estimates.
Shares of the New Jersey-based company rose about 5% in premarket trading following the results.
Here are the details:
